Telsey Advisory lowered the firm’s price target on RH (RH) to $280 from $420 and keeps an Outperform rating on the shares. The company’s Q4 results and its guidance for Q1 and FY25 fell short of expectations, the analyst tells investors. However, there are reasons to remain positive on the shares over the medium term and, while the stock is likely under pressure today and remain range bound, the firm sees upside looking further out.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RH:
- Phillip Blee’s Buy Rating on RH: Strategic Liquidity and Growth Potential Amidst Challenges
- RH price target lowered to $235 from $250 at UBS
- RH price target lowered to $220 from $510 at TD Cowen
- RH price target lowered to $300, removed from ‘Best Idea’ list at Guggenheim
- RH downgraded to Neutral from Buy at Citi